Pharmaceuticals Related News

From spider silk shoes to algae fuel, welcome to the new age of biotech

Originally published 16 Aug 2017, World Economic Forum Science makes fact out of fiction, changing our lives through new technologies. But it’s a long road from invention to adoption. Only when a technology becomes affordable and ubiquitous enough can it usually [...]

Horizon Discovery announces release of high quality, well annotated CHO genome sequence to drive innovation in bioproduction

Location: Cambridge 01/08/2017 Genome sequence is based on Horizon’s Glutamine Synthetase (GS) Knock-Out CHO K1 manufacturing-ready cell line Sequenced in collaboration with the Wellcome Trust Sanger Institute, this high value reference tool, enables the industry to screen for genes associated with [...]

By | August 5th, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Press Releases|

Intellia Therapeutics and CRISPR Therapeutics Announce U.S. Patent Covering CRISPR/Cas9 Ribonucleoprotein Complexes

CAMBRIDGE, Mass. and BASEL, Switzerland, April 26, 2017 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA) and CRISPR Therapeutics AG (NASDAQ:CRSP), two leading genome editing companies focused on the development of potentially curative therapies, announced that the United States Patent and [...]

By | May 2nd, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Press Releases|

Inovio Reports New Positive Clinical Data on Vaccine Advances in the Fight Against Emerging Infectious Diseases

PLYMOUTH MEETING, Pa., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that Dr. David B. Weiner, Inovio’s co-founder, presented positive clinical data on Inovio’s DNA-based vaccines against MERS (Middle East Respiratory Syndrome) (GLS-5300) and Zika (GLS-5700) [...]

By | February 26th, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Press Releases, Therapeutics|

Isogenica Announces New Licence Agreement with Maverick Therapeutics

CAMBRIDGE, England--(BUSINESS WIRE)--Isogenica Ltd, a leader in the design and construction of innovative and highly diverse synthetic antibody libraries, today announced a new licensing deal with Maverick Therapeutics, a private start-up biotechnology company utilising a proprietary T-cell engagement format for [...]

By | February 7th, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Press Releases|

Meet the Speakers: Will Synthetic Biology be the Key to Our Future Health?

SynBioBeta’s fifth annual London conference is fast approaching, with leaders in industry, academia, and investment once again set to converge on Imperial College London between April 4th and 6th. A full schedule of exciting events and sessions has been lined [...]

By | February 1st, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Therapeutics|